查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840698

植入式循環記錄器市場：依適應症、產品、治療部位、最終用戶和應用分類－2025-2032年全球預測

Implantable Loop Recorders Market by Indication, Product, Procedure Location, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，植入式循環記錄器市場規模將達到 43.4 億美元，複合年成長率為 11.90%。

主要市場統計數據
基準年 2024 17.6億美元
預計年份：2025年 19.7億美元
預測年份：2032年 43.4億美元
複合年成長率 (%) 11.90%

建構植入式循環記錄器的策略和臨床格局，重點關注其診斷價值、患者診療路徑以及心臟節律護理領域由創新主導的變革。

植入式循環記錄器已成為現代心臟節律管理的基礎診斷工具，因為它能夠持續、長期地檢測間歇性監測常常遺漏的發作性心律不整。過去十年，臨床醫生擴大利用這些設備來解決不明原因暈厥患者的診斷不確定性，監測中風後陣發性心搏過緩，以及對門診病人的心悸和心動過緩進行特徵分析。這種持續的臨床應用既反映了持續皮下監測的診斷效用，也反映了現代設備將安全通訊整合到臨床工作流程中的能力。

同時，設備創新降低了手術流程的複雜性，使得植入式循環記錄器得以在門診和住院環境中廣泛應用。因此，醫療服務管道正從一次性的院內診斷流程轉變為分散式模式，在這種模式下，設備植入、監測和數據審查由門診手術中心、循環系統診所甚至居家照護團隊協調完成。這種轉變對設備的性能、與電子健康記錄的互通性以及心律不整檢測演算法的準確性提出了新的要求。因此，從臨床醫生到支付方等相關人員不僅在評估植入式循環記錄器在醫療服務管道中的臨床療效，也在評估其營運影響。

展望未來，設備開發商、醫院系統和採購機構的策略規劃需要對臨床效用、流程安排和技術整合有深入的了解。為了幫助進行此類規劃，本執行摘要概述了最重要的趨勢、市場區隔考慮、區域趨勢、競爭格局以及為尋求有效且永續地部署植入式循環記錄器的決策者提供的實用建議。

植入式循環記錄器、遠端監測和診斷準確性的應用正在改變醫療保健領域的技術、臨床和護理服務模式。

植入式循環記錄器領域正經歷多重變革，這些變革正在改變設備的設計、交付和報銷方式。技術進步推動了設備的微型化和電池壽命的延長，同時提升了感測精度和演算法檢測能力。這些技術進步拓展了連續監測的臨床效用，使其涵蓋更廣泛的適應症和患者群體。同時，數位連接技術的進步，例如安全的藍牙和雲端數據傳輸，使臨床醫生能夠近乎即時地獲取數據，從而提高工作效率並縮短診斷時間。

隨著醫療器材的不斷發展，醫療服務模式也朝著分散化方向發展。門診植入管道和日間手術中心的工作流程使得手術成本更低、病患體驗更佳，並減少了對住院資源的依賴。隨著這種流程轉變的加速，醫療服務提供者正在調整護理協調、培訓通訊協定和植入監測安排，以在提高效率的同時保持醫療品質。監管和報銷環境也在不斷發展，以認可長期監測的價值，但由於覆蓋範圍和編碼方面的差異，導致不同醫療系統對長期監測的採納程度不一。

此外，分析和軟體正變得與硬體一樣，成為競爭差異化的關鍵要素。用於心房顫動檢測、偽影消除和事件分診的先進演算法正在減少假陽性結果，並提高臨床信心。隨著互通性要求的提高，能夠證明其產品可與電子健康記錄和遠端監測平台無縫整合的製造商，更有可能獲得更強大的臨床和採購支援。最後，對資料隱私和網路安全日益嚴格的審查要求供應商和提供者在其設備生命週期內提供強力的資料保護措施。總而言之，這些變化表明市場正在從以設備為中心的銷售模式轉向結合硬體、軟體和服務以提供可衡量的臨床和營運價值的解決方案。

評估美國2025年關稅對植入式循環記錄器供應鏈、製造經濟、籌資策略和臨床交付模式的累積影響

2025年美國關稅政策的實施，為植入式循環記錄器的生產和分銷帶來了新的經濟和物流變數，其累積效應波及採購和臨床部署決策。某些零件和成品設備的關稅上調，增加了依賴全球化供應鏈的製造商的成本，促使許多企業重新評估籌資策略。為此，各公司正努力實現供應商多元化，增加庫存緩衝，並加快推進近岸外包和本地化生產的討論，以降低進口成本波動帶來的風險。

這些採購應對措施也對買家和醫療服務提供者產生了間接影響。醫院和門診中心的採購團隊正在重新談判契約，並擴大供應商評估標準，將關稅風險緩解措施納入其中。因此，除了標準的醫療設備性能指標外，總擁有成本的計算現在還包括關稅、物流複雜性和潛在的前置作業時間差異。支付方和醫療系統正在透過強調基於價值的採購，並要求提供明確的證據，證明下游成本的抵消與診斷績效的提高和下游檢測的減少有關。

在產品層面，製造商正在考慮如何透過設計來減少對關稅敏感型組件的依賴，或使其能夠在不影響設備性能的前提下實現國內採購。同時，製造商與製造外包製造商之間正在建立聯盟，以分散關稅風險並維持供應的連續性。儘管這些調整會帶來短期內的複雜性，但它們也促進了長期策略調整，有利於建立更具韌性的供應鏈、採用模組化設計方法以及與供應商建立更深入的商業性夥伴關係。對於臨床領導者而言，其實際意義在於需要將供應鏈風險評估納入採購和臨床實施計劃，以確保患者能夠不間斷地獲得植入式循環記錄器技術。

整合跨適應症、產品、治療部位、終端使用者和應用的多維度細分洞察，以最佳化定位和商業化策略。

細緻的市場區隔觀點對於明確臨床價值與商業性機會之間的契合度至關重要，以下綜合分析總結了我們在市場調查中使用的關鍵細分維度。依適應症進行的分析重點在於心房顫動、心搏過緩過緩、隱性中風、心悸和暈厥。對於心房顫動，我們進一步考慮陣發性、持續性和持續性三種表現。這種臨床分類揭示了哪些患者群體最能從皮下連續監測中獲益，以及如何選擇與預期心律不整模式相符的設備。基於產品，我們重點介紹了 Biomonitor III、Confirm Rx、Lux Dx 和 Reveal Linq 等特定設備。了解產品層面的差異（感測演算法、外形尺寸、連接方式和工作流程整合）有助於相關人員做出符合營運需求和臨床醫師偏好的選擇。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 門診護理中遠距心律不整監測擴大採用微型植入式循環記錄儀
  • 將人工智慧演算法整合到ILR設備中，用於自動檢測心律不整和風險分層
  • 擴展遠端患者監護平台，將植入式心律記錄器（ILR）數據連接到遠端醫療系統，以進行持續的心臟護理。
  • 開發可充電電池技術，以延長循環記錄器的使用壽命並減少更換程序
  • 監管部門的核准加速了具備與智慧型手機即時無線連接功能的新一代循環錄音機的市場准入。

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 依適應症分類的植入式循環記錄器市場

  • 心房顫動
    • 陣發性
    • 永恆的
    • 執著的
  • 心搏過緩
  • 不明原因中風
  • 心悸
  • 昏厥

9. 植入式循環記錄器市場（依產品分類）

  • Biomonitor III
  • Confirm Rx
  • Lux Dx
  • Reveal Linq

第10章：依治療部位分類的植入式循環記錄器市場

  • 住院治療
  • 門診

第11章：以最終用戶分類的植入式循環記錄器市場

  • 門診手術中心
  • 心臟病中心
  • 居家照護
  • 醫院
    • 社區醫院
    • 三級醫療機構

第12章：按應用分類的植入式循環記錄器市場

  • 心律不整管理
    • 心搏過緩檢測
    • 心搏過速檢測
  • 隱源性中風監測
  • 診斷評估
  • 一般心臟監測

第13章：按地區分類的植入式循環記錄器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依組別分類的植入式循環記錄器市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：各國植入式循環記錄器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Abbott Laboratories
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • MicroPort Scientific Corporation
    • LivaNova PLC
    • Capso Medical, Inc.
Product Code: MRR-A339DAEF9CF2

The Implantable Loop Recorders Market is projected to grow by USD 4.34 billion at a CAGR of 11.90% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.76 billion
Estimated Year [2025] USD 1.97 billion
Forecast Year [2032] USD 4.34 billion
CAGR (%) 11.90%

Framing the strategic and clinical landscape of implantable loop recorders to highlight diagnostic value, patient pathways, and innovation-driven shifts in cardiac rhythm care

Implantable loop recorders have emerged as a foundational diagnostic tool in contemporary cardiac rhythm management, offering clinicians a continuous, long-term view into episodic arrhythmias that are often missed by intermittent monitoring. Over the last decade, clinicians have increasingly turned to these devices to resolve diagnostic uncertainty in patients with unexplained syncope, to monitor for paroxysmal atrial fibrillation following cryptogenic stroke, and to characterize palpitations and bradyarrhythmias in ambulatory populations. The sustained clinical interest reflects both the diagnostic yield of continuous subcutaneous monitoring and the ability of modern devices to integrate secure remote transmissions into clinical workflows.

Concurrently, device innovation has reduced procedural complexity and supported broader adoption across outpatient and ambulatory care settings. As a result, care pathways are shifting away from episodic, in-hospital diagnostic procedures toward distributed models where device insertion, monitoring, and data review are coordinated across ambulatory surgical centers, cardiology clinics, and even home-based care teams. These changes have created new expectations for device performance, interoperability with electronic health records, and algorithmic accuracy in arrhythmia detection. Consequently, stakeholders from clinicians to payers evaluate not only clinical efficacy but also the operational implications of introducing an implantable loop recorder into care pathways.

Looking ahead, strategic planning for device developers, hospital systems, and purchasing organizations requires a nuanced understanding of clinical utility, procedural logistics, and technology integration. To inform that planning, this executive summary synthesizes the most material trends, segmentation insights, regional dynamics, competitive behaviors, and practical recommendations that matter most to decision-makers seeking to deploy implantable loop recorders effectively and sustainably.

Charting transformative technological, clinical and care-delivery shifts reshaping implantable loop recorder adoption, remote monitoring, and diagnostic precision across care settings

The implantable loop recorder landscape is undergoing several concurrent, transformative shifts that are altering how devices are designed, delivered, and reimbursed. Technological advances are driving miniaturization and extended battery life while improving sensing fidelity and algorithmic detection. This technical progress, in turn, expands the clinical utility of continuous monitoring across a broader range of indications and patient profiles. At the same time, digital connectivity improvements-such as secure Bluetooth and cloud-enabled data transmission-are enabling near real-time clinician access to events, which enhances workflow efficiency and shortens time to diagnosis.

Parallel to device evolution, care-delivery models are decentralizing. Outpatient insertion pathways and ambulatory surgical center workflows enable lower-cost, more patient-friendly procedures, reducing the dependency on inpatient resources. As these procedural shifts accelerate, providers are adapting care coordination, training protocols, and post-implant monitoring arrangements to maintain quality while increasing throughput. Regulatory and reimbursement environments are also evolving to recognize the value of long-term monitoring, though variability in coverage and coding creates uneven adoption across health systems.

Moreover, analytics and software are becoming as central to competitive differentiation as hardware. Advanced algorithms for atrial fibrillation detection, artifact reduction, and event triage are reducing false positives and improving clinical confidence. As interoperability requirements rise, manufacturers that can demonstrate seamless integration with electronic health records and remote monitoring platforms will secure stronger clinical and procurement engagement. Finally, heightened scrutiny on data privacy and cybersecurity compels vendors and providers to embed robust protections throughout the lifecycle of device data. Taken together, these shifts underscore a market moving from device-centric selling toward solutions that combine hardware, software, and services to deliver measurable clinical and operational value.

Assessing the cumulative effects of United States 2025 tariff actions on implantable loop recorder supply chains, manufacturing economics, procurement strategies, and clinical delivery models

United States tariff actions implemented in 2025 have introduced a new variable into the economics and logistics of implantable loop recorder manufacture and distribution, with cumulative effects that ripple across procurement and clinical deployment decisions. Increased duties on specific components and finished devices have raised the cost base for manufacturers that rely on globalized supply chains, prompting many to reassess sourcing strategies. In response, firms are diversifying supplier portfolios, increasing buffer inventories, and accelerating conversations about nearshoring or regional manufacturing to reduce exposure to import-related cost volatility.

These procurement reactions have secondary consequences for buyers and care providers. Hospital and ambulatory center purchasing teams are renegotiating contracts and extending supplier evaluation criteria to include tariff risk mitigation. Consequently, the total cost of ownership calculus now integrates customs duties, logistics complexity, and potential lead-time variability in addition to standard device performance metrics. Payers and health systems are responding by emphasizing value-based purchasing and demanding clearer evidence of downstream cost offsets tied to improved diagnostic performance and reduced downstream testing.

At the product level, manufacturers are considering design choices that reduce dependence on tariff-sensitive components or that can be sourced domestically without compromising device performance. Simultaneously, alliances between manufacturers and contract manufacturers are emerging to distribute tariff risk and maintain supply continuity. While these adjustments entail short-term complexity, they also catalyze longer-term strategic realignment that favors resilient supply chains, modular design approaches, and deeper commercial partnerships with providers. For clinical leaders, the practical implication is the need to incorporate supply chain risk assessments into procurement and clinical adoption planning to ensure uninterrupted patient access to implantable loop recorder technology.

Integrating multi-dimensional segmentation insights across indications, products, procedure locations, end users, and applications to refine positioning and commercialization strategies

A fine-grained segmentation view is essential for articulating where clinical value aligns with commercial opportunity, and the following synthesis integrates the principal segmentation dimensions used to study the market. Based on Indication, analysis focuses on atrial fibrillation, bradyarrhythmia, cryptogenic stroke, palpitations, and syncope, with atrial fibrillation further examined across paroxysmal, permanent, and persistent presentations; this clinical taxonomy clarifies which patient cohorts derive the highest diagnostic yield from continuous subcutaneous monitoring and how device selection can be matched to expected arrhythmia patterns. Based on Product, the landscape includes specific device offerings such as Biomonitor III, Confirm Rx, Lux Dx, and Reveal Linq; understanding product-level differentiation-sensing algorithms, form factor, connectivity, and workflow integration-helps stakeholders align choices with operational requirements and clinician preferences.

Based on Procedure Location, the comparative dynamics between inpatient and outpatient settings reveal procedural cost structures, staffing models, and patient experience considerations that influence adoption decisions. Based on End User, deployment pathways encompass ambulatory surgical centers, cardiology centers, homecare settings, and hospitals, with hospitals further stratified into community hospitals and tertiary care hospitals; this segmentation highlights variation in procedural volume, available specialist expertise, and the degree to which integrated follow-up care is feasible. Finally, based on Application, implantable loop recorders are applied across arrhythmia management, cryptogenic stroke monitoring, diagnostic evaluation, and general cardiac monitoring, with arrhythmia management further classified into bradyarrhythmia detection and tachyarrhythmia detection; this perspective ties technical capability to clinical workflows and informs evidence-generation strategies for different use cases.

Bringing these dimensions together reveals opportunities for targeted commercialization: devices with superior long-term sensing and streamlined remote workflows fit well in outpatient and homecare settings for paroxysmal atrial fibrillation and cryptogenic stroke surveillance, while products optimized for immediate interoperability and clinician review are preferable for tertiary hospital environments addressing complex diagnostic evaluations. Strategic segmentation mapping thus enables manufacturers and providers to prioritize investment in clinical evidence, training, and integration where the interplay of indication, product attributes, procedure location, end-user capability, and application delivers the greatest operational and patient-centered benefit.

Decoding regional dynamics across the Americas; Europe, Middle East & Africa; and Asia-Pacific to reveal differentiated demand drivers, regulatory contours, and care infrastructure implications

Regional dynamics significantly influence device adoption, regulatory expectations, and commercial tactics, and a comparative lens across the Americas, Europe, Middle East & Africa, and Asia-Pacific surfaces differentiated priorities for stakeholders. In the Americas, clinical pathways increasingly favor outpatient insertion and remote follow-up, and payer models are progressively recognizing the value of long-term monitoring for stroke prevention and syncope workups. As a result, market entrants and hospital systems prioritize robust evidence demonstrating diagnostic yield and downstream cost offsets, alongside operational models that reduce reliance on inpatient resources.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement access drives varied adoption patterns; some health systems emphasize centralized procurement and health-technology-assessment-driven coverage decisions, while others adopt more decentralized models that allow innovation to diffuse through specialist centers. Local requirements for interoperability with national health records, together with regional differences in procedural reimbursement, shape clinician adoption and manufacturer go-to-market approaches.

Across Asia-Pacific, the combination of rapidly expanding cardiology infrastructure in major urban centers and a growing emphasis on outpatient care creates distinct opportunities for scalable diagnostic solutions. Regulatory pathways in the region often require region-specific clinical evidence, which encourages manufacturers to invest in targeted studies and partnerships with leading tertiary institutions. Moreover, supply chain logistics and tariff considerations vary across these regions, reinforcing the need for adaptive commercial strategies that reflect local procurement practices and clinical priorities.

Taken together, these regional contrasts underline the importance of tailoring regulatory engagement, evidence generation, and commercial models to local healthcare system incentives and patient care architectures, rather than assuming a one-size-fits-all approach to device commercialization and clinical integration.

Evaluating competitive positioning, product differentiation, partnership models, and innovation pipelines among leading implantable loop recorder manufacturers and service providers

Competitive dynamics among device manufacturers and related service providers are being shaped by a combination of hardware innovation, software-enabled diagnostic performance, and partnership-driven service delivery. Market leaders are differentiating through unique sensing algorithms, miniaturized form factors, and connectivity that supports clinician-friendly remote monitoring workflows. They are also investing in clinical evidence programs that demonstrate diagnostic accuracy and downstream clinical benefits across priority indications such as cryptogenic stroke surveillance and syncope evaluation.

Beyond product differentiation, companies are pursuing complementary strategies to secure adoption. Some emphasize direct engagement with hospital systems and ambulatory surgical centers to streamline insertion training and post-implant care pathways, while others build cooperative arrangements with remote monitoring service providers to offer an end-to-end solution. Strategic partnerships with electronic health record vendors and third-party analytics firms enhance interoperability and create stickiness among clinician users. Additionally, firms that can rapidly iterate software and algorithm updates while maintaining rigorous validation and regulatory compliance generate competitive advantage by continuously improving detection accuracy and reducing clinician burden.

Pricing and contracting strategies are also evolving. Companies are experimenting with outcome-linked service models and bundled offerings that combine device hardware with monitoring subscriptions and analytics. These commercial constructs seek to align incentives with healthcare purchasers who emphasize measurable clinical and operational value. Finally, supply chain resilience, including localized manufacturing options and diversified component sourcing, is emerging as a non-trivial competitive differentiator in the wake of recent trade policy shifts, since vendors that can demonstrate reliable delivery and tariff risk mitigation provide tangible procurement advantages to health systems.

Actionable strategic recommendations for industry leaders to accelerate adoption, optimize value-based interventions, and mitigate supply chain and regulatory headwinds in implantable loop recorders

Industry leaders should pursue a balanced set of strategic initiatives that accelerate adoption while protecting operational continuity and clinical quality. First, prioritize clinical evidence programs that align with payer and guideline-maker needs, focusing on indications where continuous monitoring demonstrably improves diagnostic yield and patient management. Complement these trials with real-world evidence projects that showcase outcomes across outpatient and homecare settings to support broader coverage conversations.

Second, invest in seamless interoperability and clinician workflow integration. Solutions that reduce time to event review, minimize false alerts, and integrate effortlessly with electronic health records will encounter lower resistance from overstretched cardiology teams. Third, strengthen supply chain resilience by diversifying component suppliers, exploring regional manufacturing partnerships, and modeling tariff exposure in procurement planning. These steps will preserve service continuity and protect margin amid policy shifts.

Fourth, adopt innovative commercial models that align vendor incentives with healthcare purchaser goals. Bundled offerings, performance-linked contracts, and subscription-based monitoring services can reduce upfront barriers to adoption and demonstrate shared commitment to improving patient outcomes. Fifth, expand training and adoption programs that equip ambulatory surgical centers, cardiology clinics, and homecare teams with standardized insertion, monitoring, and escalation protocols to maintain quality as procedures decentralize. Finally, embed robust data governance and cybersecurity practices into product design and service delivery to maintain clinician and patient trust while fulfilling regulatory obligations. Taken together, these actions will position firms and provider organizations to convert technological capability into sustainable clinical and commercial impact.

Transparent research methodology describing data sources, analytical frameworks, stakeholder engagements, and validation steps underpinning the implantable loop recorder analysis

This analysis draws upon a mixed-methods research approach designed to combine clinical insight, commercial intelligence, and operational context. Primary research included structured interviews and workshops with practicing electrophysiologists, cardiologists, procurement leaders, and clinical operations managers to capture real-world perspectives on device performance, insertion workflows, and monitoring burdens. Secondary research comprised a systematic review of clinical literature, guideline statements, regulatory filings, and product technical documentation to ground findings in validated evidence and recognized standards of care.

Quantitative device performance attributes and product specifications were analyzed alongside qualitative input to map value drivers across clinical indications and care settings. Triangulation of data sources enabled corroboration of claims around sensing fidelity, battery performance, connectivity options, and integration capabilities. Validation steps included expert panel reviews and follow-up interviews with clinical adopters to ensure that inferences about workflow impact and adoption hurdles reflected operational reality.

Limitations are acknowledged: rapidly evolving software features and post-market software updates can change device performance profiles, and regulatory or reimbursement shifts may alter commercial dynamics after data collection. To mitigate these constraints, the study focused on durable clinical and operational themes and documented the methodological assumptions underpinning interpretation. The resulting framework is intended to be actionable for decision-makers while transparent about evidence provenance and analytical boundaries.

Synthesis of core findings and strategic implications to guide executive decision making on clinical integration, go-to-market alignment, and long-term investment priorities for implantable loop recorders

The cumulative assessment converges on several strategic imperatives for stakeholders engaged with implantable loop recorders. Technological advancements and improved analytics are enhancing diagnostic precision and enabling broader use across ambulatory and home-based care pathways. At the same time, procedural decentralization and rising expectations for interoperability are reshaping the attributes that matter most to clinicians and purchasers. Regulatory and payer environments continue to lag in some jurisdictions, creating a patchwork of access that demands localized commercialization strategies.

Operationally, supply chain and trade policy developments have introduced new dimensions of risk that require proactive mitigation through diversified sourcing and regional manufacturing planning. Commercially, vendors that bundle hardware with proven analytics, monitoring service models, and integration capabilities will achieve stronger traction, particularly where evidence demonstrates clinical benefit and operational efficiency. Providers and health systems can accelerate value realization by standardizing care pathways for device insertion and post-implant monitoring and by investing in clinician training to manage increased remote data flows.

In summary, implantable loop recorders are shifting from niche diagnostic adjuncts to integral components of comprehensive cardiac rhythm management strategies. The organizations that succeed will pair clinical credibility with operational excellence, resilient supply chains, and commercial models aligned with purchaser needs. Executives should therefore prioritize evidence generation, interoperability, and procurement resilience as immediate areas of focus to translate the technology's promise into sustained clinical and financial outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of miniaturized implantable loop recorders for remote arrhythmia monitoring in outpatient settings
  • 5.2. Integration of artificial intelligence algorithms in ILR devices for automated arrhythmia detection and risk stratification
  • 5.3. Expansion of remote patient monitoring platforms connecting ILR data to telehealth systems for continuous cardiac care
  • 5.4. Development of rechargeable battery technology in loop recorders to extend device lifespan and reduce replacement procedures
  • 5.5. Regulatory approvals driving market entry of next-generation loop recorders with real-time wireless connectivity to smartphones

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Loop Recorders Market, by Indication

  • 8.1. Atrial Fibrillation
    • 8.1.1. Paroxysmal
    • 8.1.2. Permanent
    • 8.1.3. Persistent
  • 8.2. Bradyarrhythmia
  • 8.3. Cryptogenic Stroke
  • 8.4. Palpitations
  • 8.5. Syncope

9. Implantable Loop Recorders Market, by Product

  • 9.1. Biomonitor Iii
  • 9.2. Confirm Rx
  • 9.3. Lux Dx
  • 9.4. Reveal Linq

10. Implantable Loop Recorders Market, by Procedure Location

  • 10.1. Inpatient
  • 10.2. Outpatient

11. Implantable Loop Recorders Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiology Centers
  • 11.3. Homecare Settings
  • 11.4. Hospitals
    • 11.4.1. Community Hospitals
    • 11.4.2. Tertiary Care Hospitals

12. Implantable Loop Recorders Market, by Application

  • 12.1. Arrhythmia Management
    • 12.1.1. Bradyarrhythmia Detection
    • 12.1.2. Tachyarrhythmia Detection
  • 12.2. Cryptogenic Stroke Monitoring
  • 12.3. Diagnostic Evaluation
  • 12.4. General Cardiac Monitoring

13. Implantable Loop Recorders Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Implantable Loop Recorders Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Implantable Loop Recorders Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Abbott Laboratories
    • 16.3.3. BIOTRONIK SE & Co. KG
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. MicroPort Scientific Corporation
    • 16.3.6. LivaNova PLC
    • 16.3.7. Capso Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. IMPLANTABLE LOOP RECORDERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. IMPLANTABLE LOOP RECORDERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMPLANTABLE LOOP RECORDERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PAROXYSMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PAROXYSMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PAROXYSMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PAROXYSMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PAROXYSMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PAROXYSMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERMANENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERMANENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERMANENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERMANENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERMANENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERMANENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERSISTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERSISTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERSISTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERSISTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERSISTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PERSISTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PALPITATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PALPITATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PALPITATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PALPITATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PALPITATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PALPITATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SYNCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SYNCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SYNCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SYNCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SYNCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SYNCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BIOMONITOR III, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BIOMONITOR III, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BIOMONITOR III, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BIOMONITOR III, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BIOMONITOR III, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BIOMONITOR III, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CONFIRM RX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CONFIRM RX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CONFIRM RX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CONFIRM RX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CONFIRM RX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CONFIRM RX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY LUX DX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY LUX DX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY LUX DX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY LUX DX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY LUX DX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY LUX DX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REVEAL LINQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REVEAL LINQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REVEAL LINQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REVEAL LINQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REVEAL LINQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REVEAL LINQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY OUTPATIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY BRADYARRHYTHMIA DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TACHYARRHYTHMIA DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TACHYARRHYTHMIA DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TACHYARRHYTHMIA DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TACHYARRHYTHMIA DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TACHYARRHYTHMIA DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY TACHYARRHYTHMIA DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY CRYPTOGENIC STROKE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GENERAL CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GENERAL CARDIAC MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GENERAL CARDIAC MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GENERAL CARDIAC MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GENERAL CARDIAC MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY GENERAL CARDIAC MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ARRHYTHMIA MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY ATRIAL FIBRILLATION, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY PROCEDURE LOCATION, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA IMPLANTABLE LOOP RECORDERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA IMP